Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias
- PMID: 2190685
- PMCID: PMC1451984
Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias
Abstract
Elevated plasma levels of cholesterol and triglycerides, low levels of high-density lipoproteins, hypertension, diabetes mellitus, smoking and abdominal obesity are risk factors for coronary heart disease (CHD) and stroke. Because of the preventable threat to life, well-being and productivity from perturbations of plasma lipoproteins (which affect about 60% of adults), we recommend a population-based strategy with public education on diet, exercise and the hazards of smoking and legislation for better food labelling. This should be combined with the medical guidelines we describe to detect and treat those at highest risk for CHD (including about 15% of adults), who merit priority for the medical, dietetic and laboratory services required. Among people aged 40 years or more this includes those with plasma total cholesterol levels greater than 7 mmol/L, fasting triglyceride levels greater than 3 mmol/L or cholesterol level greater than 6 mmol/L when associated with CHD or other risk factors for CHD. For younger people the criteria for highest risk include cholesterol levels greater than 6.5 mmol/L for those aged 30 to 39 years, greater than 6 mmol/L for those aged 20 to 29 and greater than 5 mmol/L for those under age 20.
Comment in
-
Detecting and treating dyslipoproteinemias.CMAJ. 1990 Oct 1;143(7):607-9. CMAJ. 1990. PMID: 2207913 Free PMC article. No abstract available.
Comment on
-
Determining lipid risk factors for coronary heart disease.CMAJ. 1989 Mar 1;140(5):493. CMAJ. 1989. PMID: 2634969 Free PMC article. No abstract available.
Similar articles
-
Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.Can J Cardiol. 1999 Apr;15(4):428-33. Can J Cardiol. 1999. PMID: 10322252
-
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.Arch Intern Med. 1996 Jun 10;156(11):1181-8. Arch Intern Med. 1996. PMID: 8639012 Clinical Trial.
-
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.Can J Cardiol. 1997 Mar;13(3):253-60. Can J Cardiol. 1997. PMID: 9117913
-
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.Am Heart J. 2002 Dec;144(6 Suppl):S33-42. doi: 10.1067/mhj.2002.130301. Am Heart J. 2002. PMID: 12486414 Review.
-
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.Curr Med Res Opin. 2004 Aug;20(8):1253-68. doi: 10.1185/030079904125004402. Curr Med Res Opin. 2004. PMID: 15324528 Review.
Cited by
-
[Diagnosis of dyslipidemia in primary care: a service to be improved. Results of a multicenter evaluation].Aten Primaria. 2000 Feb 15;25(2):82-8. doi: 10.1016/s0212-6567(00)78468-x. Aten Primaria. 2000. PMID: 10736937 Free PMC article. Spanish.
-
Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.PLoS One. 2013 Jul 26;8(7):e67611. doi: 10.1371/journal.pone.0067611. Print 2013. PLoS One. 2013. PMID: 23922649 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources